Fortschritte der Neurologie-Psychiatrie · 2013
[First occurrence of an organic manic schizophreniform syndrome followed by catatonia induced by anti-NMDA-receptor encephalitis].
Клинический случайАннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fousse M, Becker C, Faßbender K, Reith W, Körner H, Alexandrou M, Spiegel J
Аннотация
We report on a 39-year-old female patient who developed catatonia after there had been schizomanic symptoms in the six months before. At admission the patient exhibited catatonia, a tetraspastic syndrome and focal epileptic seizures. The cranial MRI revealed bilateral subcortical hyperintense lesions which took up contrast agent. Examination of the cerebrospinal fluid disclosed a lymphocytic pleocytosis and autochthone oligoclonal bands. In the serum autoantibodies against the NMDA-NR-1 receptor were reproducibly detected. A detailed search for a tumour was negative. In detail, we could exclude a neoplasm of the ovaries which is often present in the paraneoplastic type of anti-NMDA-receptor encephalitis. Therefore we assume an autoimmune, not paraneoplastic, encephalitis in our patient. The symptoms improved significantly after an immunosuppressive therapy - initially with glucocorticoids followed by rituximab - had been initiated. This case illustrates that an autoimmune encephalitis should be looked for when first psychotic symptoms occur.
Предметные рубрики MeSH
Adrenal Cortex HormonesAdultAnti-Inflammatory AgentsAnti-N-Methyl-D-Aspartate Receptor EncephalitisAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsAutoantibodiesAutoimmune DiseasesBipolar DisorderCatatoniaElectroencephalographyEpilepsies, PartialFemaleHumansImmunosuppressive AgentsMagnetic Resonance ImagingPsychotic DisordersReceptors, N-Methyl-D-AspartateRituximab